dbi ( diazepam-binding inhibitor ) is a putative neuromodulatory peptide isolated from rat brain that acts on gamma-aminobutyric acid-benzodiazepine-cl- ionophore receptor complex inducing beta-carboline-like effects .
C0057738
diazepam-binding inhibitor
C0030956
peptide